HOME
SEARCH
RSS FEED
SUBSCRIBE
Search Results - drug+delivery
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Targeted Nanocarriers for Brain Inflammation and Cancer Cachexia
Nanocarriers deliver anti-inflammatory therapeutics across the blood-brain barrier to activated microglia Background Delivering therapeutics to the brain remains a major drug-development challenge because the blood-brain barrier restricts systemic agents from reaching therapeutically relevant concentrations in the central nervous system. This barrier...
Published: 5/7/2026
|
Updated: 5/7/2026
|
Inventor(s):
Oleh Taratula
,
Olena Taratula
,
Yoon Tae Goo
Keywords(s):
anti-inflammatory
,
Anti-inflammatory drugs
,
biodegradable
,
biodistribution
,
blood-brain barrier
,
brain delivery
,
brain inflammation
,
CNS
drug delivery
,
cytokine expression
,
Drug Delivery
,
Drug Development
,
glutathione
,
immune cell
,
immunohistochemistry
,
irak4 inhibitor
,
lipopolysaccharides
,
microglia
,
mouse model
,
nanocarrier
,
nanocarriers
,
nanomedicine
,
neuroinflammation
,
pancreatic cancer
,
pharmaceuticals
,
pharmacokinetics
,
preservation
,
pro-inflammatory cytokine
,
small molecules
,
water-soluble
,
weight maintenance
Category(s):
Therapeutics
mRNA Therapeutic Against the SARS-CoV-2 Spike Protein
Background Vaccines have shown great efficacy against SARS-CoV-2, the pathogen of COVID-19; however, methods of treatment are required for patients suffering from COVID‑19. More than 15 million cases with over 600,000 deaths have resulted from the ongoing coronavirus disease 2019 (COVID-19). SARS-CoV-2, the pathogen of COVID-19, is a β-coronavirus...
Published: 8/4/2025
|
Updated: 12/16/2021
|
Inventor(s):
Gaurav Sahay
,
Anindit Mukherjee
,
Jeonghwan Kim
Keywords(s):
antiviral
,
Drug
,
Drug Delivery
,
mRNA
,
mRNA carrier
,
mRNA delivery
Category(s):
Therapeutics
Lymphatic
drug delivery
system and drugs for metastatic melanoma
Technology Description Oregon State University is seeking a licensee for a patented
drug delivery
system for the treatment of metastatic melanoma. The system is composed of biodegradable, biocompatible, and stable nanoparticles built from amphiphilic block copolymers and contains a mix of drugs commonly used to treat cancer, all while being nontoxic...
Published: 1/16/2023
|
Updated: 11/23/2015
|
Inventor(s):
Adam Alani
Keywords(s):
Cancer
,
Drug
,
Drug Delivery
,
drugs
,
lymphatic
,
melanoma
,
metastatic tumor
,
pharmaceuticals
,
Therapeutic
Category(s):
Therapeutics
Home
|
Search
|
RSS
|
Subscribe
© 2026. All Rights Reserved. Powered by
Inteum